High Burden and Persistent Detection of Kodamaea ohmeri Bloodstream Infection Among Neonates in Bangladesh: A Prospective Hospital-Based Surveillance

Kodamaea ohmeri is an emerging invasive fungal pathogen, with limited data from low- and middle-income countries. We describe the epidemiology, clinical characteristics, and outcomes of neonatal K. ohmeri bloodstream infection in two tertiary care hospitals in Bangladesh. We conducted prospective surveillance among neonates admitted to neonatal intensive care units of two tertiary care hospitals between August 2022 and June 2026. Fungal isolates were identified using VITEK 2 and confirmed using VITEK MS. Antifungal susceptibility testing (AFST) was performed on a subset of isolates using two gradient diffusion strip tests. Among 770 enrolled neonates, 12.3% (n = 95) had bloodstream infection caused by K. ohmeri, accounting for 27.1% of all positive fungal isolates. Clinical characteristics were comparable between K. ohmeri and other fungal infections. Among the positive K. ohmeri cases, 57.9% (n = 55) received antifungal therapy. AFST showed relatively higher fluconazole MICs than voriconazole, amphotericin B, and echinocandins. However, mortality was numerically lower among patients who received antifungal therapy than among those who did not, although the association was not statistically significant in either unadjusted (p = 0.09) or adjusted (p = 0.065) analyses. The high burden and associated mortality of K. ohmeri bloodstream infections highlight the importance of strengthening species-level fungal identification and antifungal stewardship in resource-limited NICUs. Continued surveillance and further investigations linking antifungal susceptibility with clinical outcomes are warranted to inform evidence-based management.

Authors

Institutions

Publication Details

Journal
Microorganisms
Published
2026-11-12
DOI
https://doi.org/10.3390/microorganisms14112624
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

High Burden and Persistent Detection of Kodamaea ohmeri Bloodstream Infection Among Neonates in Bangladesh: A Prospective Hospital-Based Surveillance

Nandita Banik, Sayeeda Huq, Shams E. Tabriz Bhuiyan, Tanzir Ahmed Shuvo et al.
Microorganisms
Antifungal resistance and susceptibility
article

High Burden and Persistent Detection of Kodamaea ohmeri Bloodstream Infection Among Neonates in Bangladesh: A Prospective Hospital-Based Surveillance

Nandita Banik, Sayeeda Huq, Shams E. Tabriz Bhuiyan, Tanzir Ahmed Shuvo, Ismet Nigar, Tahsinul Amin, Debashis Sen, Laila Kabir, Jesmin Akter, Nusrat Jahan Shaly, Fahmida Chowdhury, Zakir Hossain Habib, Sazzad Bin Shahid, Adiba Tasnim, Gazi Md. Salahuddin Mamun, Fahmida Dil Farzana, Mohammad Abdul Aleem, Md Abdul Mannan, Mahbuba Chowdhury, Md Kamrul Islam, Saima Binte Golam Rasul, Faiyaz Ahmed Khan, Farhat Jaby Pammi, Ayesha Afrin, Sifat Binte Ibrahim, Md. Shoieb Ul Haque, Md. Kamrujjaman Howladar, Tasnim Bakir Rafa, Aleza Sharmin Ema, Nuzhat Shamiha Alam, Farzana Alam
article en

Abstract

Kodamaea ohmeri is an emerging invasive fungal pathogen, with limited data from low- and middle-income countries. We describe the epidemiology, clinical characteristics, and outcomes of neonatal K. ohmeri bloodstream infection in two tertiary care hospitals in Bangladesh. We conducted prospective surveillance among neonates admitted to neonatal intensive care units of two tertiary care hospitals between August 2022 and June 2026. Fungal isolates were identified using VITEK 2 and confirmed using VITEK MS. Antifungal susceptibility testing (AFST) was performed on a subset of isolates using two gradient diffusion strip tests. Among 770 enrolled neonates, 12.3% (n = 95) had bloodstream infection caused by K. ohmeri, accounting for 27.1% of all positive fungal isolates. Clinical characteristics were comparable between K. ohmeri and other fungal infections. Among the positive K. ohmeri cases, 57.9% (n = 55) received antifungal therapy. AFST showed relatively higher fluconazole MICs than voriconazole, amphotericin B, and echinocandins. However, mortality was numerically lower among patients who received antifungal therapy than among those who did not, although the association was not statistically significant in either unadjusted (p = 0.09) or adjusted (p = 0.065) analyses. The high burden and associated mortality of K. ohmeri bloodstream infections highlight the importance of strengthening species-level fungal identification and antifungal stewardship in resource-limited NICUs. Continued surveillance and further investigations linking antifungal susceptibility with clinical outcomes are warranted to inform evidence-based management.

MicroorganismsVol. 14(11)
Bangladesh Medical University (BD), International Centre for Diarrhoeal Disease Research (BD), Institute of Epidemiology, Disease Control and Research (BD), Dhaka Medical College and Hospital (BD)
Centers for Disease Control and Prevention
Good health and well-being
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon